Reported 223,114 shares, down 488,048 (68.6%) from the prior quarter.
Reported value -84.8%; share count -68.6% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-12-31 | 2661667 |
| 2026-03-31 | 11602879 |
| 2026-06-30 | 23610578 |
| 2026-09-30 | 3594367 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 223,114 | -488,048 (-68.6%) | < 0.01% | $3,594,367 | 2026-11-16 | |
| Q2 2026 | Added | 711,162 | +245,370 (52.7%) | 0.03% | $23,610,578 | 2026-08-14 | |
| Q1 2026 | Added | 465,792 | +235,743 (102.5%) | 0.02% | $11,602,879 | 2026-05-15 | |
| Q4 2025 | New | 230,049 | +230,049 (0.0%) | < 0.01% | $2,661,667 | 2026-02-17 |
Who else reported the position
115 managers reported SUTRO BIOPHARMA INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BVF INC IL | Unchanged | 1,251,788 | 0 | 0.66% | $20,166,305 | 3 qtrs |
| BlackRock Inc | Added | 1,178,196 | +55,541 | < 0.01% | $18,980,738 | 4 qtrs |
| Affinity Asset Advisors LLC | Reduced | 1,152,487 | -20,000 | 0.76% | $18,566,566 | 4 qtrs |
| Samsara BioCapital LLC | Unchanged | 1,062,872 | 0 | 1.63% | $17,122,868 | 4 qtrs |
| PERCEPTIVE ADVISORS LLC | Reduced | 970,846 | -334,000 | 0.27% | $15,640,329 | 3 qtrs |
| Kynam Capital Management LP | Unchanged | 872,558 | 0 | 0.78% | $14,056,909 | 4 qtrs |
| ORBIMED ADVISORS LLC | Unchanged | 743,944 | 0 | 0.22% | $11,984,938 | 3 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 676,926 | -17,293 | < 0.01% | $10,905,278 | 3 qtrs |
| ACADIAN ASSET MANAGEMENT LLC | Added | 557,868 | +184,029 | 0.01% | $8,977,000 | 4 qtrs |
| Velan Capital Investment Management LP | Reduced | 510,038 | -2,122 | 7.84% | $8,216,712 | 4 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM SHS
Voting authority reported
- Sole
- 223,114
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.